Jobs / United States / Astrazeneca Pharmaceuticals Lp
Director, Global Insights & Forecasting, Early Assets & Business Development
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Global Development Medical Director” (Medical Scientists, Except Epidemiologists) in NY: $331k–$331k, median $331k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Director, Global Insights & Forecasting, Early Assets & Business Development (R&I) You will play a pivotal role in guiding critical investment decisions across AstraZeneca's industry-leading R&I pipeline — from pre-clinical stages through Phase 3 readiness , as well as in-licensing and business development opportunities . You will translate complex scientific, epidemiological, and market dynamics into decision-grade forecasts and actionable insights that shape therapeutic area strategy and unlock long-term value. This is a highly visible role that partners directly with senior leaders across Global Early Commercial, Finance, Market Access, Medical, and Business Development , offering the chance to influence portfolio direction while championing the adoption of AI, automation, and next-generation analytics across the organization. Key Responsibilities • Forecasting & Scenario Modeling: Build and refine early forecasts and scenario analyses covering epidemiology, market adoption curves, competitive dynamics, and policy shifts to support stage-gate decision-making. • Patient-Based Forecast Development: Construct robust patient-based forecast models integrating primary and secondary data inputs, benchmarked against internal and external analogs to inform investment decisions. • Business Development Support: Deliver commercial diligence and market models for in-licensing opportunities, partnerships, and acquisitions . • Executive Decision Support: Provide clear, decision-oriented narratives for governance reviews, executive updates, portfolio prioritization, and opportunity assessments. • Strategic Advisory: Act as a trusted advisor to senior leaders, articulating forecast drivers, model changes, external signals, and strategic implications with clarity and confidence. • Therapeutic Area Strategy: Contribute as a core member of the Disease Strategy Team , helping to shape long-term R&I strategy. • Market Research Leadership: Design and oversee vendor-led qualitative and quantitative market research to support investment decisions and therapeutic area planning. • AI & Innovation: Identify and embed AI-enabled approaches — including machine learning, generative AI, agentic workflows, and automation — to enhance speed, quality, explainability, and scalability of insights. • Governance & Responsible AI: Champion strong data and model governance, documentation, responsible AI practices, and transparent explainability to reinforce business confidence and manage risk appropriately. Mandatory Requirements • Bachelor's degree required in scientific area. • 6+ years of relevant experience in the pharmaceutical, biotech, or consulting industry, with a focus on forecasting, portfolio strategy, business development and market insights . • Strong scientific and business acumen , with the ability to bridge technical and commercial perspectives. • Scientific agility to quickly assess new indications, modalities, and biological targets. • Solid understanding of commercial drivers, market access dynamics, pricing, reimbursement, and policy factors . • Excellent communication skills — able to translate complex data into clear, actionable recommendations for senior stakeholders and governance forums. Desirable Requirements • Advanced degree strongly preferred ( MBA, MS, or PhD in a quantitative, scientific, or life-sciences discipline). • Therapeutic area expertise in Respiratory and/or Immunology . • Hands-on experience designing and leading qualitative and quantitative primary market research . • Familiarity with secondary and syndicated data sources — including medical claims, EHR/EMR, IQVIA Rx, and sales data — with proficiency in interpreting large, longitudinal patient-level datasets. • Change leadership experience: building